[1] Akin F, Yaylali GF, Bastemir M. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients. Med Princ Pract, 2008, 17(2): 167-170.  doi: 10.1159/000112975
[2] Bogazzi F, Bartalena L, Brogioni S, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves'hyperthyroidism. J Clin Endocrinol Metab, 1999, 84(2): 499-503.
[3] Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid, 2002, 12(5): 399-405.  doi: 10.1089/105072502760043486
[4] Dunkelmann S, Künstner H, Nabavi E, et al. Lithium as an adjunct to radioiodine therapy in Graves'disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not?. Nuklearmedizin, 2006, 45(5): 213-218.  doi: 10.1055/s-0038-1625222
[5] 王长修. 低摄131I率Graves病患者131I治疗时加用碳酸锂的临床价值. 中国误诊学杂志, 2006, 6(1): 32.  doi: 10.3969/j.issn.1009-6647.2006.01.015
[6] Bogazzi F, Bartalena L, Campomori A, et al. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves'disease. J Clin Endocrinol Metab, 2002, 87(10): 4490-4495.  doi: 10.1210/jc.2002-020580
[7] Ng YW, Tiu SC, Choi KL, et al. Use of lithium in the treatment of thyrotoxicosis. Hong Kong Med J, 2006, 12(4): 254-259.
[8] Hoogenberg K, Beentjes JA, Piers DA. Lithium as an adjunct to radioactive iodine in treatment-resistant Graves thyrotoxicosis. Ann Intern Med, 1998, 129(8): 670.
[9] Barbaro D, Grosso M, Boni G, et al. Recombinant hurman TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer the effect of pre-treatment with furosemide and furosemide plus lithium. Eur J Nucl Med Mol Imaging, 2010, 37(2): 242-249.  doi: 10.1007/s00259-009-1254-2
[10] 李舜, 林映芬, 张家云, 等. 碳酸锂与丙基硫氧嘧啶对Graves病重型甲亢131碘疗效影响的比较. 中国现代医学杂志, 2005, 15(19): 2963-2965.
[11] 杨宾, 王伟, 翁孝刚, 等. 131I联合碳酸锂治疗Graves病疗效观察. 中国误诊学杂志, 2006, 6(11): 2111-2112.  doi: 10.3969/j.issn.1009-6647.2006.11.061
[12] 赵辉, 张智勇, 徐晓红, 等. 131I合并小剂量碳酸锂治疗老年性甲状腺机能亢进的临床探讨. 临床内科杂志, 2007, 24(10): 716.  doi: 10.3969/j.issn.1001-9057.2007.10.029
[13] Tang SW. Using lithium. Hong Kong Med J, 2006, 12(4): 253.
[14] Kirov G. Thyroid disorders in lithium-treated patients. J Affect Disord, 1998, 50(1): 33-40.  doi: 10.1016/S0165-0327(98)00028-7
[15] Dalan R, Leow MK, Jong M. Multiple endocrinopathies associated with lithium therapy. Endocr Pract, 2007, 13(7): 758-763.  doi: 10.4158/EP.13.7.758
[16] Saunders BD, Saunders EF, Gauger PG. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg, 2009, 33(11): 2314-2323.  doi: 10.1007/s00268-009-9942-4
[17] Arlt S, Burkhardt D, Wiedemann K. Thyrotoxicosis after iodine contrast medium administration: rapid mood swing to mania and subsequent psychotic depression in a patient with bipolar disorder during lithium therapy. Pharmacopsychiatry, 2008, 41(4): 163-165.  doi: 10.1055/s-2008-1076723
[18] Cayköylü A, Capolu I, Unüvar N, et al. Thyroid abnormalities in lithium-treated patients with bipolar affective disorder. J Int Med Res, 2002, 30(1): 80-84.  doi: 10.1177/147323000203000112
[19] 管昌田. 131I治疗甲亢的最佳化. 国外医学·放射医学核医学分册, 1997, 21(5): 252-256.
[20] Mijnhout GS, Franken AA. Antithyroid drug regimens before and after 131I-therapy for hyperthyroidism: evidence-based?. Neth J Med, 2008, 66(6): 238-241.
[21] Dunkelmann S, Kuenstner H, Nabavi E, et al. Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves'disease. Eur J Nucl Med Mol Imaging, 2007, 34(2): 228-236.  doi: 10.1007/s00259-006-0234-z
[22] Burch HB, Solomon L, Cooper DS, et al. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after(131)I ablation for Graves' disease. J Clin Endocrinol Metab, 2001, 86(7): 3016-3021.
[23] Bogazzi F, Bartalena L, Pinchera A, et al. Adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid, 2002, 12(12): 1153-1154.  doi: 10.1089/105072502321085298
[24] 查金顺, 张桂仙, 舒娜翎, 等. 甲亢用131I治疗前后动态检测甲状腺功能变化的临床研究. 标记免疫分析与临床, 1999, 6(3): 135-140.
[25] Turner JG, Brownlie BE, Rogers TG. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. Lancet, 1976, 1(7960): 614-615.
[26] Vannucchi G, Chiti A, Mannavola D, et al. Radioiodine treatment of non-toxic multinodular goitre: effects of combination with lithium. Eur J Nucl Med Mol Imaging, 2005, 32(9): 1081-1088.  doi: 10.1007/s00259-005-1818-8
[27] Oszukowska L, Knapska-Kucharska M, Makarewicz J, et al. The influence of thiamazole, lithium carbonate, or prednisone administration on the efficacy of radioiodine treatment((131)I) in hyperthyroid patients. Endokrynol Pol, 2010, 61(1): 56-61.